Literature DB >> 31845436

Industry influence and Health Canada's responsibility: lessons from the opioid epidemic in Canada.

Itai Bavli1.   

Abstract

Keywords:  Drug safety; Health Canada; OxyContin; Purdue Pharma; opioids; pharmaceutical industry; physicians; postmarketing; prescribing promotion

Mesh:

Substances:

Year:  2020        PMID: 31845436     DOI: 10.1111/add.14929

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  2 in total

1.  Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020.

Authors:  Wayne Jones; Ridhwana Kaoser; David Rudoler; Benedikt Fischer
Journal:  J Pharm Policy Pract       Date:  2022-03-29

2.  On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data.

Authors:  Jessie Pappin; Itai Bavli; Matthew Herder
Journal:  Clin Trials       Date:  2022-08-04       Impact factor: 2.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.